Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1038.38x is 43% below its 4-year average of -727.25x, near the high end of its 4-year range (-3511.00x–-8.00x).
44.38% above its 12-month average of -1866.84x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -3511.00x.
INTEREST COVERAGE RATIO
-1038.38x
INTEREST COVERAGE RATIO AVG TTM
-1866.84x
INTEREST COVERAGE RATIO AVG 3Y
-851.42x
INTEREST COVERAGE RATIO AVG 5Y
-727.25x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+44.38%
CURRENT VS 3Y AVG
-21.96%
CURRENT VS 5Y AVG
-42.78%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 520 covered companies
CURRENT VS SECTOR MEDIAN
-16188.31%
vs the sector median at left
PAVmed Inc.
Market Cap
$17.27M
Interest Coverage Ratio
-1038.38x
TTM Avg
-1866.84x
3Y Avg
-851.42x
5Y Avg
-727.25x
Market Cap
$16.78M
Interest Coverage Ratio
-1288.77x
TTM Avg
51.73x
3Y Avg
51.73x
5Y Avg
51.73x
Market Cap
$17.11M
Interest Coverage Ratio
N/A
TTM Avg
15.47x
3Y Avg
15.47x
5Y Avg
15.47x
Market Cap
$17.50M
Interest Coverage Ratio
-6.31x
TTM Avg
0.97x
3Y Avg
0.97x
5Y Avg
0.97x
Market Cap
$16.67M
Interest Coverage Ratio
N/A
TTM Avg
1.00x
3Y Avg
1.00x
5Y Avg
1.00x
Market Cap
$17.71M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.70M
Interest Coverage Ratio
-111.88x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.50M
Interest Coverage Ratio
-49.05x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.44M
Interest Coverage Ratio
-15.67x
TTM Avg
0.81x
3Y Avg
0.81x
5Y Avg
0.81x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PAVmed Inc. (PAVM) | $17.27M | -1038.38x | -1866.84x | -851.42x | -727.25x |
| Palatin Technologies, Inc. (PTN)vs › | $16.78M | -1288.77x | 51.73x | 51.73x | 51.73x |
| Lipocine Inc. (LPCN)vs › | $17.11M | N/A | 15.47x | 15.47x | 15.47x |
| Cosmos Health Inc. (COSM)vs › | $17.50M | -6.31x | 0.97x | 0.97x | 0.97x |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.67M | N/A | 1.00x | 1.00x | 1.00x |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.71M | N/A | N/A | N/A | N/A |
| Bionano Genomics, Inc. (BNGO)vs › | $16.70M | -111.88x | N/A | N/A | N/A |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.50M | -49.05x | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.44M | -15.67x | 0.81x | 0.81x | 0.81x |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.54M | N/A | N/A | N/A | N/A |
Interest Coverage
-1038.4x
Debt/Equity
0.49
Current Ratio
1.19
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -3511.00x |
| 2026-03-31 | -2678.33x |
| 2025-12-31 | -1360.60x |
| 2025-09-30 | -605.50x |
| 2025-06-30 | -1178.75x |
| 2025-03-31 | -1361.50x |
| 2024-12-31 | -741.00x |
| 2024-09-30 | -964.83x |
| 2024-06-30 | -1244.00x |
| 2024-03-31 | -877.25x |
| 2023-12-31 | -862.26x |
| 2023-09-30 | -97.66x |
| 2023-06-30 | -72.30x |
| 2023-03-31 | -111.48x |
| 2022-12-31 | -110.32x |
| 2022-09-30 | -44.51x |
| 2022-06-30 | -44.90x |
| 2021-12-31 | -8.00x |
| 2020-09-30 | -110.56x |
| 2020-06-30 | -25.07x |
| 2020-03-31 | -11.37x |
| 2019-12-31 | -7.87x |
| 2018-12-31 | -4.84x |
| 2018-09-30 | -3.63x |
| 2018-06-30 | -5.47x |
| 2018-03-31 | -3.89x |
| 2017-12-31 | -5.21x |
| 2017-09-30 | -5.43x |
